A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology.

In vitro studies pinpoint signaling pathways that could be potential targets in oral squamous cell carcinoma treatments.

Cancer is often perceived as a fate, but what if it could be avoided even before it manifests? Scientists have just taken a significant step in that direction. Their work on mice reveals that ...

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...

Many forms of cancer are devastating. But pancreatic cancer is one of the most deadly and aggressive forms there is. There are several reasons for this, including its stealthy progression, rapid ...

Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer treatments, according to a study led by Dr. Martin Taylor at the Warren Alpert ...